Sources: SURMOUNT-1 (NEJM 2022), LEADER trial (NEJM 2016), Victoza prescribing information
Preclinical trials conducted on rats demonstrate measurable improvements in transected tendon reattachment and Achilles tendon rupture models, though human clinical data remain limited
At 68 weeks, the treatment-regimen estimand results were -20.0% (9 mg dose, approximately 50.5 pounds) and -23.7% (12 mg dose, approximately 60 pounds)
Cata-Kor, a US-based longevity-focused nutraceutical company, has released results from independent laboratory testing of 12 top-selling glutathione supplements purchased from Amazon's website in April 2026
Healthcare providers should assess heart rate and blood pressure both at the start of treatment and throughout its course, especially for patients with arrhythmias or heart failure
Tirzepatida (Mounjaro, Zepbound): Inyeccin semanal